Endothelial Cell Loss After Penetrating Keratoplasty

Alexandria University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Keratoconus

Treatments: Procedure: PKP

Study type: Interventional

Funder types: Other

Identifiers

NCT04457063

0304624

Details and patient eligibility

About

This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.

Full description

Penetrating keratoplasty (PKP) is considered a safe and effective procedure.This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.

Enrollment: 8 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction

Exclusion criteria

• Less than 18 and unable to give informed consent

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

penetrating keratoplasty

Experimental group

Description:

A prospective non-comparative non-randomized clinical study which was conducted on 12 eyes of 8 patients 4 males and 4 females who underwent PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction

Treatment:

Procedure: PKP